期刊文献+

突发性聋患者血清HIF-α、内脂素、Caspase-3与听力损伤程度的关系及预测听力预后的价值

Relationship between serum HIF-α,Visfatin,Caspase-3 and degree of hearing impairment in sudden deafness patients and its predictive value for hearing prognosis
下载PDF
导出
摘要 目的:探讨突发性聋患者血清缺氧诱导因子-α(HIF-α)、内脂素(Visfatin)、Caspase-3与听力损伤程度的关系及预测听力预后的价值。方法:收集113例突发性聋患者,其中轻度听力损伤32例,中度57例,重度24例。给以激素、改善循环、营养神经等药物治疗,10~15 d后评估听力预后,评价血清HIF-α、Visfatin、Caspase-3水平对听力预后的预测价值。结果:重度听力损伤患者血清HIF-α、Visfatin、Caspase-3水平高于轻、中度患者,中度听力损伤患者高于轻度患者(P<0.05)。预后不良患者血清HIF-α、Visfatin、Caspase-3水平高于预后良好患者(P<0.05)。血清HIF-α、Visfatin、Caspase-3水平与听力预后有关,OR(95%CI)分别为4.546(1.572~13.149)、3.782(1.306~10.952)、5.917(2.441~14.345)(P<0.05)。三者联合预测听力预后的敏感度为88.46%,特异度为90.80%,AUC为0.934(95%CI 0.871~0.972),高于单独预测[HIF-α、Visfatin、Caspase-3单独预测的AUC(95%CI)分别为0.717(0.625~0.798)、0.719(0.626~0.799)、0.747(0.656~0.824)]。结论:突发性聋患者血清HIF-α、Visfatin、Caspase-3水平与听力损伤程度有关,联合检测可用于预测听力预后。 Aim:To investigate the relationship between serum hypoxia-inducible factor-α(HIF-α),Visfatin,Caspase-3 and the degree of hearing impairment in sudden deafness patients and its predictive value for hearing prognosis.Methods:A total of 113 patients with sudden deafness were selected,including 32 cases of mild hearing loss,57 cases of moderate hearing loss,and 24 cases of severe hearing loss.Medications such as hormone therapy,improving circulation,and nourishing nerves were administered.After 10 to 15 days of treatment,the prognosis of hearing,and the predictive value of serum HIF-α,Visfatin and Caspase-3 for hearing prognosis was evaluated.Results:Serum HIF-α,Visfatin,Caspase-3 levels in patients with severe hearing impairment were higher that those with mild,moderate hearing impairment,and those with moderate hearing impairment were higher than those with mild hearing impairment(P<0.05).Serum HIF-α,Visfatin,Caspase-3 levels were higher in patients with poor prognosis than those with good prognosis(P<0.05).Serum HIF-α,Visfatin,Caspase-3 were associated with hearing prognosis,OR(95%CI)were 4.546(1.572-13.149),3.782(1.306-10.952),5.917(2.441-14.345)(P<0.05).AUC of the combination of the 3 factors was 0.934(95%CI 0.871-0.972),with a sensitivity of 88.46%and specificity of 90.80%,which was greater than that of the prediction alone,and AUC(95%CI)of serum HIF-α,Visfatin,Caspase-3 alone were 0.717(0.625-0.798),0.719(0.626-0.799),0.747(0.656-0.824).Conclusion:The serum levels of HIF-α,Visfatin and Caspase-3 in patients with sudden deafness are correlated with the degree of hearing impairment,and the combined detection could be used to predict hearing prognosis.
作者 朱晓丹 郝少娟 王漾 叶放蕾 ZHU Xiaodan;HAO Shaojuan;WANG Yang;YE Fanglei(Department of Otology,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052)
出处 《郑州大学学报(医学版)》 CAS 北大核心 2023年第3期399-403,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关计划省部共建项目(201901039)。
关键词 突发性聋 缺氧诱导因子-Α 内脂素 CASPASE-3 听力损伤程度 听力预后 sudden deafness hypoxia-inducible factor-α Visfatin Caspase-3 degree of hearing impairment hearing prognosis
  • 相关文献

参考文献7

二级参考文献103

  • 1谌祎玮,周建波,谢昀,李金徽,胡丽立.银杏达莫注射液联合地塞米松治疗突发性耳聋的疗效及对血清sVCAM-1、CGRP水平的影响[J].现代生物医学进展,2019,19(23):4565-4568. 被引量:25
  • 2杨伟炎,杨仕明.关于突发性聋诊断和疗效标准的讨论[J].中华耳鼻咽喉头颈外科杂志,2006,41(5):324-325. 被引量:33
  • 3突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):569-569. 被引量:852
  • 4杨晓琦,余力生,马鑫.耳后注射复方倍他米松治疗顽固性低频型感音神经性聋[J].中华耳鼻咽喉头颈外科杂志,2007,42(11):814-816. 被引量:86
  • 5Moschen AR,Kaser A,Enrich B. Visfatin,an adipocytokine with proinflammatory and immunomodulating properties[J].Journal of Immunology,2007,(03):1748-1758.
  • 6Duchene J,Lecomte F,Ahmed S. A novel inflammatory pathway involved in leukocyte recruitment:role for the kinin B1 receptor and the chemokine ENA-78[J].Immunology,2007,(07):4849-4856.
  • 7Zhong M,Tan HW,Gong HP. Increased serum visfatin in patients with metabolic syndrome and carotid a the roscle rosis[J].Clinical Endocrinology,2008,(06):878-884.doi:10.1111/j.1365-2265.2008.03248.x.
  • 8Dahl TB,Yndestad A,Skjelland M. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis possible role in inflammation and plaque destabilization[J].Circulation,2007,(08):972-980.
  • 9Lim SY,Davidson SM,Paramanathan AJ. The novel adipocytokine visfatin exerts direct cardioprotective effects[J].Journal of Molecular Medicine,2008,(04):1395-1403.
  • 10Adya R,Tan BK,Punn A. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signaling pathways:novel insights into visfatin induced angiogenesis[J].Cardiovascular Research,2008,(02):356-365.

共引文献1359

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部